Determining the survival benefit of adjuvant radiotherapy in patients with node-positive head and neck cancer [0.03%]
选择性辅助放疗在淋巴结阳性头颈部癌症患者中生存收益的评估
Giuseppe Sanguineti,Arlene A Forastiere
Giuseppe Sanguineti
Whether postoperative radiotherapy improves survival compared with surgery alone in patients with head and neck cancer remains unclear. This Practice Point commentary discusses the findings of a study by Kao et al. who used the Surveillance...
Radiation oncology health technology assessment: the best is the enemy of the good [0.03%]
放射肿瘤学卫生技术评估：最好往往是敌人的好
Søren M Bentzen
Søren M Bentzen
Cancer fatigue syndrome reflects clinically non-overt heart failure: an approach towards onco-cardiology [0.03%]
癌症疲劳综合征反映临床未显现出的心力衰竭：一种面向肿瘤心脏病学的方法
Martin Schünemann,Stefan D Anker,Mathias Rauchhaus
Martin Schünemann
Therapy insight: Management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy [0.03%]
癌症患者心血管疾病的治疗及抗癌治疗引起的心脏并发症
Aarif Y Khakoo,Edward T H Yeh
Aarif Y Khakoo
Cardiac disease in patients with cancer or caused by cancer therapy is a clinical problem of emerging importance. Optimum management of cardiovascular disease can mean that patients with cancer can successfully receive therapies to treat th...
Treatment of diffuse large B-cell lymphoma of the liver with yttrium-90 microsphere embolization [0.03%]
采用钇-90微球栓塞治疗弥漫性大B细胞肝淋巴瘤
Timothy S Fenske,Heather Benjamin,Steven H Kroft et al.
Timothy S Fenske et al.
Background: A 41-year-old male with a 4-year history of chronic hepatitis C presented with a 1-month history of abdominal pain, fatigue, weight loss, and night sweats. ...
Phuong Dinh,Evandro de Azambuja,Fatima Cardoso et al.
Phuong Dinh et al.
The human epidermal growth factor receptor-2 (HER2) is overexpressed and/or amplified in up to 25% of breast cancer patients, and this feature is associated with an aggressive phenotype, high recurrence rate and reduced survival. Until rece...
Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma [0.03%]
新诊断的多发性骨髓瘤患者使用沙利度胺和地塞米松进行初次治疗的效果研究
Meletios A Dimopoulos,Efstathios Kastritis
Meletios A Dimopoulos
Thalidomide with dexamethasone (thal-dex) is an active therapy for patients with relapsed or refractory multiple myeloma (MM). In this Practice Point, we discuss the findings of a trial by Rajkumar et al. that aimed to compare the response ...
Choosing a taxane for adjuvant treatment of breast cancer: more than a flip of the coin? [0.03%]
选择紫杉烷类药物作为乳腺癌术后治疗：不仅仅是随机选择了？
Linda Vahdat
Linda Vahdat
This Practice Point commentary discusses the findings of a trial that assessed the efficacy of weekly (QW) versus once every 3 weeks (Q3W) paclitaxel or docetaxel after doxorubicin-and-cyclophosphamide-based chemotherapy in patients with no...
Brian I Rini
Brian I Rini
Lapatinib is an oral dual inhibitor of EGFR and HER2, the coexpression of which is associated with metastatic disease in patients with renal cell carcinoma. A recent randomized phase III trial of lapatinib versus hormone therapy was conduct...
Trials and tribulations [0.03%]
挫折与收获
Vincent T DeVita Jr
Vincent T DeVita Jr